Interplay between integrins, growth factors and mapk in epidermal proliferation

Project Information

ANNA RUIZ NEL-LO

Grant agreement ID: QLG1-CT-2000-52142

Project closed

Start date 18 April 2001

End date 17 April 2003

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 114 272,00

EU contribution € 114 272,00

Coordinated by

CANCER RESEARCH UK
United Kingdom

Objective

Chronic hyperproliferative epidermal disorders such as psoriasis affect 2% of the world’s population. The aim of this project is to investigate the possible interplay between MAPK, growth factors and integrins in epidermal hyper proliferation

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

CANCER RESEARCH UK

• EU contribution: No data
• Address: Lincolns Inn Field 44 ; WC2A 3PX LONDON ; United Kingdom
• Total cost: No data